Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers

Purpose To analyse the effects of intravitreal dexamethasone implant (DEX) in patients with diabetic macular oedema (DME) unresponsive to ranibizumab treatment, in relation to the inflammatory optical coherence tomography (OCT) retinal features, subfoveal neuroretinal detachment (SND) and hyperrefle...

Full description

Saved in:

Bibliographic details
Volume:	97
Main Author:	Bonfiglio, Vincenza Reibaldi, Michele Pizzo, Alessandra Russo, Andrea Macchi, Iacopo Faro, Giuseppe Avitabile, Teresio Longo, Antonio
Format:	Journal Article
Language:	English
Zielgruppe:	Academic
Place of publication:	HOBOKEN WILEY 01.06.2019 Wiley Subscription Services, Inc
published in:	Acta ophthalmologica (Oxford, England) Vol. 97; no. 4; pp. e540 - e544
ORCID:	0000-0001-5468-0978
Data of publication:	June 2019
ISSN:	1755-375X 1755-3768
EISSN:	1755-3768
Discipline:	Medicine
Subjects:	dexamethasone diabetes retinopathy best‐corrected visual acuity optical coherence tomography diabetic macular oedema ranibizumab Life Sciences & Biomedicine Ophthalmology Science & Technology Diabetic retinopathy Dropsy Edema Dexamethasone Analysis Central nervous system depressants Tomography Steroids Index Medicus dexamethasone FACTOR THERAPY diabetes retinopathy EFFICACY optical coherence tomography diabetic macular oedema best-corrected visual acuity DETACHMENT ranibizumab ENDOTHELIAL GROWTH-FACTOR
Online Access:	Fulltext
Database:	Web of Science - Science Citation Index Expanded - 2019 Web of Knowledge Science Citation Index Expanded Web of Science PubMed CrossRef Academic OneFile (A&I only) MEDLINE - Academic Database information Databases - DBIS